AURX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AURX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.
As of today (2024-12-11), Nuo Therapeutics's Volatility is 158.77%.
For the Biotechnology subindustry, Nuo Therapeutics's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Nuo Therapeutics's Volatility distribution charts can be found below:
* The bar in red indicates where Nuo Therapeutics's Volatility falls into.
The annualized volatility is calculated as following:
σA | = | σM | * | √12 |
= | √ 1/(n-1) ∑(Ri - R')^2 | * | √12 |
Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nuo Therapeutics (OTCPK:AURX) Volatility Explanation
Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.
Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.
Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Thank you for viewing the detailed overview of Nuo Therapeutics's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.
Charles E Sheedy | 10 percent owner | TWO HOUSTON CENTER, SUITE 2907, HOUSTON TX 77010 |
David Emerson Jorden | director, officer: CEO, CFO | 2635 TECHNOLOGY FOREST BLVD., THE WOODLANDS TX 77381 |
Lawrence Atinsky | director | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
C Eric Winzer | director | |
Paul Mintz | director | C/O NUO THERAPEUTICS INC., 207A PERRY PARKWAY, SUITE 1, GAITHERSBURG MD 20877 |
Peter Clausen | officer: CSO | 11204 JEFFRO COURT, IJAMSVILLE MD 21754 |
Scott M. Pittman | director | 3683 JOHN NASH BLVD., BLUEFIELD WV 24701 |
Boyalife Investment Fund I, Inc. | 10 percent owner | 2453 S. ARCHER AVE., SUITE B, CHICAGO IL 60616 |
Dean Tozer | officer: CHIEF COMMERCIAL OFFICER | C/O ADVANCED BIOHEALING, INC., 36 CHURCH LANE, WESTPORT CT 06880 |
Steven A Shallcross | officer: SEE REMARKS | C/O ELYS GAME TECHNOLOGY CORP., 130 ADELAIDE STREET WEST, SUITE 701, TORONTO A6 M5H2K4 |
Aldagen Holdings, Llc | 10 percent owner, other: May be part of a 13(d) group | C/O THOMAS A. ALLEN, ESQ., 4101 LAKE BOONE TRAIL, STE 300, RALEIGH NC 27607 |
Kathryne Carr | 10 percent owner, other: May be part of a 13(d) group | 315 OLD IVY WAY, SUITE 101, CHARLOTTESVILLE VA 22903 |
William W Brooke | 10 percent owner, other: May be part of a 13(d) group | 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203 |
Guercio Joseph Del | director | C/O CLARK INVESTMENTS, 7500 OLD GEORGETOWN ROAD, SUITE 620, BETHESDA MD 20814 |
B. Jefferson Clark | 10 percent owner, other: May be part of a 13(d) group | C/O ALDAGEN, INC., 2810 MERDIAN PARKWAY, SUITE 148, DURHAM NC 27713 |
From GuruFocus
By PRNewswire PRNewswire • 10-07-2020
By GuruFocusNews GuruFocusNews • 02-04-2022
By Ds*** Ds*** • 08-30-2022
By PRNewswire PRNewswire • 03-22-2019
By GlobeNewswire GlobeNewswire • 02-04-2022
By Marketwired • 06-22-2023
By PRNewswire PRNewswire • 04-20-2021
By Marketwired • 06-26-2023
By PRNewswire PRNewswire • 01-16-2019
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.